(CIDRAP News) A panel set up by the World Health Organization (WHO) to review its pandemic response spent the last day of its 3-day meeting yesterday hearing from an expert who denied charged that drug companies swayed response activities and said it may be premature to declare that the pandemic is over, according to media reports.
(CIDRAP News) A committee of experts appointed by the World Health Organization (WHO) convened today to begin evaluating the agency's and the world's response to the H1N1 influenza pandemic, with WHO Director-General Margaret Chan urging the group to pull no punches.
(CIDRAP News) The National Biodefense Science Board today capped a hurried review by recommending that the federal government launch a major effort to better focus its activities to develop medical countermeasures (MCMs) for chemical, biological, radiological, and nuclear (CBRN) threats, starting by choosing at least three new countermeasures for priority efforts.
(CIDRAP News) A committee that advises the US Department of Health and Human Services on biodefense issues took the first steps today to meet the tough assignment of analyzing the challenges facing HHS's medical countermeasures program and completing a report by Mar 26.
(CIDRAP News) A comprehensive review of the nation's tools for reducing the impact of a biological weapons attack or other public health emergencyprompted in part by last fall's delays in delivery of the pandemic H1N1 vaccineis due to get under way in the next few weeks with a pair of conferences.
Editor's note: This story was revised after initial posting to specify which arm of the CDC issued the statement described.
(CIDRAP News) Officials at the Centers for Disease Control and Prevention (CDC) yesterday rejected a contention from several professional groups that its guidance on respiratory protection for healthcare workers caring for H1N1 patients was influenced by a recent controversial study by Australian researchers.
A reanalysis prompted by reviewers has changed the conclusions of a study comparing N-95 respirators with surgical masks, raising questions about earlier findings that the N-95 devices were clearly more effective in protecting healthcare workers from respiratory illness.
(CIDRAP News) The US Centers for Disease Control and Prevention (CDC) today issued eagerly awaited recommendations on pandemic H1N1 infection control in healthcare settings, which affirms its earlier guidance on N-95 respirators but spells out other options for when the respirators are in short supply.
(CIDRAP News) – In findings sure to renew the continuing controversy over respiratory protection for healthcare workers, surgical masks appeared to protect hospital nurses from influenza about as well as N-95 respirators did in a randomized trial conducted in Ontario.